Litcius/Paper detail

Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe

Mrinank Sharma, Sören Mindermann, Darren Smith, Gavin Leech, Benedict Snodin, Janvi Ahuja, Jonas B. Sandbrink, Joshua Teperowski Monrad, George Altman, Gurpreet Dhaliwal, Lukas Finnveden, Alexander John Norman, Sebastian Oehm, Julia Fabienne Sandkühler, Laurence Aitchison, Tomáš Gavenčiak, Thomas A. Mellan, Jan Kulveit, Leonid Chindelevitch, Seth Flaxman, Yarin Gal, Swapnil Mishra, Samir Bhatt, Jan Brauner

2021Nature Communications228 citationsDOIOpen Access PDF

Abstract

European governments use non-pharmaceutical interventions (NPIs) to control resurging waves of COVID-19. However, they only have outdated estimates for how effective individual NPIs were in the first wave. We estimate the effectiveness of 17 NPIs in Europe's second wave from subnational case and death data by introducing a flexible hierarchical Bayesian transmission model and collecting the largest dataset of NPI implementation dates across Europe. Business closures, educational institution closures, and gathering bans reduced transmission, but reduced it less than they did in the first wave. This difference is likely due to organisational safety measures and individual protective behaviours-such as distancing-which made various areas of public life safer and thereby reduced the effect of closing them. Specifically, we find smaller effects for closing educational institutions, suggesting that stringent safety measures made schools safer compared to the first wave. Second-wave estimates outperform previous estimates at predicting transmission in Europe's third wave.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakGovernment (linguistics)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Psychological interventionPandemicVirologyPolitical scienceMedicineOutbreakPsychiatryPathologyPhilosophyInfectious disease (medical specialty)DiseaseLinguisticsCOVID-19 epidemiological studiesCOVID-19 Pandemic ImpactsVaccine Coverage and Hesitancy